Australia Markets close in 4 hrs 14 mins

Zealand Pharma A/S (ZEAL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
23.09+0.01 (+0.04%)
At close: 2:14PM EST
Currency in USD

Valuation measures

Market cap (intra-day) 5N/A
Enterprise value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7N/A

Trading information

Stock price history

Beta (5Y monthly) 0.85
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 340.00
52-week low 321.19
50-day moving average 329.35
200-day moving average 330.49

Share statistics

Avg vol (3-month) 34.45k
Avg vol (10-day) 38.19k
Shares outstanding 543.48M
Implied shares outstanding 6N/A
Float 835.97M
% held by insiders 10.00%
% held by institutions 13.82%
Shares short (30 Aug 2021) 4126.67k
Short ratio (30 Aug 2021) 42.22
Short % of float (30 Aug 2021) 4N/A
Short % of shares outstanding (30 Aug 2021) 40.29%
Shares short (prior month 29 July 2021) 4159.71k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 June 2021


Profit margin 0.00%
Operating margin (ttm)-447.90%

Management effectiveness

Return on assets (ttm)-33.63%
Return on equity (ttm)-72.06%

Income statement

Revenue (ttm)252.03M
Revenue per share (ttm)6.09
Quarterly revenue growth (yoy)-61.80%
Gross profit (ttm)262.75M
Net income avi to common (ttm)-1.15B
Diluted EPS (ttm)-3.66
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.28B
Total cash per share (mrq)29.66
Total debt (mrq)143.77M
Total debt/equity (mrq)10.37
Current ratio (mrq)4.19
Book value per share (mrq)38.52

Cash flow statement

Operating cash flow (ttm)-1.07B
Levered free cash flow (ttm)-566.99M